MCAT
Basic information
Region (hg38): 22:43132209-43143398
Links
Phenotypes
GenCC
Source:
- autosomal recessive optic atrophy (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Optic atrophy 15 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 31915829; 33918393 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MCAT gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 16 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 16 | 3 | 4 |
Variants in MCAT
This is a list of pathogenic ClinVar variants found in the MCAT region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-43133055-C-A | Benign (Jun 12, 2018) | |||
22-43133070-G-T | not specified | Uncertain significance (Mar 18, 2024) | ||
22-43133088-C-G | Benign (Feb 08, 2018) | |||
22-43133128-A-G | not specified | Uncertain significance (Mar 07, 2023) | ||
22-43133152-C-T | not specified | Uncertain significance (Dec 28, 2023) | ||
22-43133177-C-T | Uncertain significance (Jul 01, 2021) | |||
22-43133213-C-T | not specified | Uncertain significance (Dec 28, 2023) | ||
22-43133288-C-T | not specified | Uncertain significance (Apr 09, 2024) | ||
22-43133371-G-A | not specified | Uncertain significance (Apr 25, 2023) | ||
22-43133387-C-T | not specified | Uncertain significance (Dec 17, 2023) | ||
22-43133393-C-T | Optic atrophy 15 | Pathogenic (Nov 13, 2023) | ||
22-43133404-G-A | Uncertain significance (Nov 13, 2023) | |||
22-43133438-T-C | not specified | Likely benign (Nov 06, 2023) | ||
22-43133441-G-A | not specified | Uncertain significance (Mar 07, 2024) | ||
22-43137099-C-G | Benign (Feb 25, 2018) | |||
22-43137131-C-T | not specified | Uncertain significance (Aug 02, 2022) | ||
22-43137157-A-G | not specified | Uncertain significance (Jul 16, 2021) | ||
22-43137175-C-T | not specified | Likely benign (Dec 28, 2022) | ||
22-43137176-G-A | - | no classification for the single variant (-) | ||
22-43141086-T-C | Benign (May 01, 2023) | |||
22-43141251-T-C | Optic atrophy 15 | Pathogenic (Nov 13, 2023) | ||
22-43143021-G-A | not specified | Uncertain significance (Jan 04, 2024) | ||
22-43143060-C-A | not specified | Uncertain significance (Jan 10, 2023) | ||
22-43143107-A-C | - | no classification for the single variant (-) | ||
22-43143114-G-C | MCAT-related condition | Likely benign (Nov 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MCAT | protein_coding | protein_coding | ENST00000290429 | 4 | 11189 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000306 | 0.819 | 125699 | 0 | 49 | 125748 | 0.000195 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.291 | 202 | 214 | 0.944 | 0.0000120 | 2471 |
Missense in Polyphen | 83 | 89.661 | 0.9257 | 996 | ||
Synonymous | -0.767 | 105 | 95.5 | 1.10 | 0.00000609 | 820 |
Loss of Function | 1.19 | 7 | 11.3 | 0.619 | 5.68e-7 | 136 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000550 | 0.000535 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000173 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000232 | 0.000229 |
Middle Eastern | 0.000173 | 0.000163 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000490 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the transfer of a malonyl moiety from malonyl- CoA to the free thiol group of the phosphopantetheine arm of the mitochondrial ACP protein (NDUFAB1). This suggests the existence of the biosynthesis of fatty acids in mitochondria. {ECO:0000269|PubMed:12882974}.;
- Pathway
- Fatty acid biosynthesis - Homo sapiens (human);Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Metabolism;Fatty acid metabolism;fatty acid biosynthesis initiation
(Consensus)
Recessive Scores
- pRec
- 0.318
Intolerance Scores
- loftool
- 0.538
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 50.34
Haploinsufficiency Scores
- pHI
- 0.222
- hipred
- N
- hipred_score
- 0.180
- ghis
- 0.472
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.695
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mcat
- Phenotype
- adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); muscle phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; digestive/alimentary phenotype; skeleton phenotype;
Gene ontology
- Biological process
- fatty acid biosynthetic process;fatty acid beta-oxidation
- Cellular component
- mitochondrion;mitochondrial matrix
- Molecular function
- RNA binding;fatty acid synthase activity;[acyl-carrier-protein] S-malonyltransferase activity